Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

68 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Tumor-initiating capacity of CD138- and CD138+ tumor cells in the 5T33 multiple myeloma model.
Van Valckenborgh E, Matsui W, Agarwal P, Lub S, Dehui X, De Bruyne E, Menu E, Empsen C, van Grunsven L, Agarwal J, Wang Q, Jernberg-Wiklund H, Vanderkerken K. Van Valckenborgh E, et al. Among authors: van grunsven l. Leukemia. 2012 Jun;26(6):1436-9. doi: 10.1038/leu.2011.373. Epub 2012 Jan 6. Leukemia. 2012. PMID: 22289925 Free PMC article. No abstract available.
Endothelial cell-driven regulation of CD9 or motility-related protein-1 expression in multiple myeloma cells within the murine 5T33MM model and myeloma patients.
De Bruyne E, Andersen TL, De Raeve H, Van Valckenborgh E, Caers J, Van Camp B, Delaissé JM, Van Riet I, Vanderkerken K. De Bruyne E, et al. Among authors: van valckenborgh e, van camp b, van riet i. Leukemia. 2006 Oct;20(10):1870-9. doi: 10.1038/sj.leu.2404343. Epub 2006 Aug 10. Leukemia. 2006. PMID: 16900214 Free article.
The effects of JNJ-26481585, a novel hydroxamate-based histone deacetylase inhibitor, on the development of multiple myeloma in the 5T2MM and 5T33MM murine models.
Deleu S, Lemaire M, Arts J, Menu E, Van Valckenborgh E, King P, Vande Broek I, De Raeve H, Van Camp B, Croucher P, Vanderkerken K. Deleu S, et al. Among authors: van valckenborgh e, van camp b. Leukemia. 2009 Oct;23(10):1894-903. doi: 10.1038/leu.2009.121. Epub 2009 Jun 4. Leukemia. 2009. PMID: 19494837
Imaging and radioimmunotherapy of multiple myeloma with anti-idiotypic Nanobodies.
Lemaire M, D'Huyvetter M, Lahoutte T, Van Valckenborgh E, Menu E, De Bruyne E, Kronenberger P, Wernery U, Muyldermans S, Devoogdt N, Vanderkerken K. Lemaire M, et al. Among authors: van valckenborgh e. Leukemia. 2014 Feb;28(2):444-7. doi: 10.1038/leu.2013.292. Epub 2013 Oct 9. Leukemia. 2014. PMID: 24166214 No abstract available.
68 results